ABSTRACT
Background Genome-wide association studies (GWAS) have identified common, heritable alleles that increase late-onset Alzheimer’s disease (LOAD) risk. We recently published an analytic approach to integrate GWAS and phenome-wide association study (PheWAS) data, enabling identification of candidate traits and trait-associated variants impacting disease risk, and apply it here to LOAD.
Methods PheWAS was performed for 23 known LOAD-associated single nucleotide polymorphisms (SNPs) and 4:1 matched control SNPs using UK Biobank data. Traits enriched for association with LOAD SNPs were ascertained and used to identify trait-associated candidate SNPs to be tested for association with LOAD risk (17,008 cases; 37,154 controls).
Results LOAD-associated SNPs were significantly enriched for associations with 6/778 queried traits, including three platelet traits. The strongest enrichment was for platelet distribution width (PDW) (P=1.2×10−5), but no consistent direction of effect was observed between increased PDW and LOAD susceptibility across variants or in Mendelian randomization analysis. Of 384 PDW-associated SNPs identified by prior GWAS, 36 were nominally associated with LOAD risk and 5 survived false-discovery rate correction for multiple testing. Associations confirmed known LOAD risk loci near PICALM, CD2AP, SPI1, and NDUFAF6, and identified a novel risk locus in the epidermal growth factor receptor (EGFR) gene.
Conclusions Through integration of GWAS and PheWAS data, we identify substantial pleiotropy between genetic determinants of LOAD and of platelet morphology, and for the first time implicate EGFR – a mediator of β-amyloid toxicity – in Alzheimer’s disease susceptibility.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Neuroscience Initiative of Translating Duke Health (CEW, KMW), the Infectious Diseases Society of America Foundation's "Microbial Pathogenesis in Alzheimer's Disease" grant (KMW, CEW, ECS), and the National Institute on Aging of the National Institutes of Health under Award Number P30AG072958 (ASK, KMW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study leverages publicly available human data, which can be obtained from UK Biobank and the I-GAP Consortium. http://geneatlas.roslin.ed.ac.uk/ https://www.niagads.org/datasets/ng00036
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of interest disclosure: The authors declare no competing interests.
Financial support: This study was supported by the Neuroscience Initiative of Translating Duke Health (CEW, KMW), the Infectious Diseases Society of America Foundation’s “Microbial Pathogenesis in Alzheimer’s Disease” grant (KMW, CEW, ECS), and the National Institute on Aging of the National Institutes of Health under Award Number P30AG072958 (ASK, KMW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Data Availability
This study leverages publicly available human data, which can be obtained from UK Biobank and the I-GAP Consortium.
